These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques. De Rose R; Batten CJ; Smith MZ; Fernandez CS; Peut V; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Venturi V; Davenport MP; Kent SJ J Virol; 2007 Jan; 81(1):292-300. PubMed ID: 17050602 [TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques: induction of humoral and cellular immune responses. Richardson MW; Mirchandani J; Silvera P; Régulier EG; Capini C; Bojczuk PM; Hu J; Gracely EJ; Boyer JD; Khalili K; Zagury JF; Lewis MG; Rappaport J DNA Cell Biol; 2002 Sep; 21(9):637-51. PubMed ID: 12396606 [TBL] [Abstract][Full Text] [Related]
27. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques. Yamamoto H; Kawada M; Tsukamoto T; Takeda A; Igarashi H; Miyazawa M; Naruse T; Yasunami M; Kimura A; Matano T J Gen Virol; 2007 Feb; 88(Pt 2):652-659. PubMed ID: 17251584 [TBL] [Abstract][Full Text] [Related]
28. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518 [TBL] [Abstract][Full Text] [Related]
29. Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaques. Mee ET; Berry N; Ham C; Sauermann U; Maggiorella MT; Martinon F; Verschoor EJ; Heeney JL; Le Grand R; Titti F; Almond N; Rose NJ Immunogenetics; 2009 May; 61(5):327-39. PubMed ID: 19337730 [TBL] [Abstract][Full Text] [Related]
30. Influence of the MHC genotype on the progression of experimental SIV infection in the Mauritian cynomolgus macaque. Aarnink A; Dereuddre-Bosquet N; Vaslin B; Le Grand R; Winterton P; Apoil PA; Blancher A Immunogenetics; 2011 May; 63(5):267-74. PubMed ID: 21234560 [TBL] [Abstract][Full Text] [Related]
31. Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail. Nehete PN; Nehete BP; Hill L; Manuri PR; Baladandayuthapani V; Feng L; Simmons J; Sastry KJ Virology; 2008 Jan; 370(1):130-41. PubMed ID: 17920095 [TBL] [Abstract][Full Text] [Related]
33. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection. Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828 [TBL] [Abstract][Full Text] [Related]
34. Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection. Li H; Omange RW; Czarnecki C; Correia-Pinto JF; Crecente-Campo J; Richmond M; Li L; Schultz-Darken N; Alonso MJ; Whitney JB; Plummer FA; Luo M J Med Primatol; 2017 Aug; 46(4):137-143. PubMed ID: 28748659 [TBL] [Abstract][Full Text] [Related]
35. Unusually high frequency MHC class I alleles in Mauritian origin cynomolgus macaques. Krebs KC; Jin Z; Rudersdorf R; Hughes AL; O'Connor DH J Immunol; 2005 Oct; 175(8):5230-9. PubMed ID: 16210628 [TBL] [Abstract][Full Text] [Related]
36. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs. Ui M; Kuwata T; Igarashi T; Ibuki K; Miyazaki Y; Kozyrev IL; Enose Y; Shimada T; Uesaka H; Yamamoto H; Miura T; Hayami M Virology; 1999 Dec; 265(2):252-63. PubMed ID: 10600597 [TBL] [Abstract][Full Text] [Related]
37. Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection. ten Haaft P; Almond N; Biberfeld G; Cafaro A; Cranage M; Ensoli B; Hunsmann G; Polyanskaya N; Stahl-Hennig C; Thortensson R; Titti F; Heeney J J Med Primatol; 2001 Aug; 30(4):207-14. PubMed ID: 11555139 [TBL] [Abstract][Full Text] [Related]
38. Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. Patterson LJ; Malkevitch N; Venzon D; Pinczewski J; Gómez-Román VR; Wang L; Kalyanaraman VS; Markham PD; Robey FA; Robert-Guroff M J Virol; 2004 Mar; 78(5):2212-21. PubMed ID: 14963117 [TBL] [Abstract][Full Text] [Related]
39. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques. McDermott AB; O'Connor DH; Fuenger S; Piaskowski S; Martin S; Loffredo J; Reynolds M; Reed J; Furlott J; Jacoby T; Riek C; Dodds E; Krebs K; Davies ME; Schleif WA; Casimiro DR; Shiver JW; Watkins DI J Virol; 2005 Dec; 79(24):15556-66. PubMed ID: 16306626 [TBL] [Abstract][Full Text] [Related]
40. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Belyakov IM; Hel Z; Kelsall B; Kuznetsov VA; Ahlers JD; Nacsa J; Watkins DI; Allen TM; Sette A; Altman J; Woodward R; Markham PD; Clements JD; Franchini G; Strober W; Berzofsky JA Nat Med; 2001 Dec; 7(12):1320-6. PubMed ID: 11726972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]